清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

HEXIM1: a new player in myocardial hypertrophy?

心脏病学 心肌肥大 肌肉肥大 医学 内科学
作者
Daniele Catalucci,Gianluigi Condorelli
出处
期刊:Cardiovascular Research [Oxford University Press]
卷期号:99 (1): 1-3 被引量:4
标识
DOI:10.1093/cvr/cvt134
摘要

This editorial refers to ‘Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse’ by M.M. Montano et al., pp. 74–82, this issue. Cardiac hypertrophy is a consequential response to stress; however, not all types of hypertrophy are the same. In fact, the molecular signatures underlying different forms of hypertrophy depend on the type of stress and of the subsequent activated signalling cascade. Preferential activation of specific signal transduction cascades, such as the calcineurin and MAPK pathways, is characteristic for pathological cardiac hypertrophy (e.g. in response to ventricular pressure overload), while the PI3 K/Akt/mTOR signalling cascade seems to be preferentially activated in exercise- or IGF1-dependent physiological hypertrophy.1–3 Remarkably, the activation of each signalling pathway is not specific but rather preferential for one type of hypertrophy. For instance, the PI3 K/Akt pathway is activated in both pressure-overload and exercise-induced cardiac hypertrophy.2,4 Akt induction indirectly activates mTOR, which, in turn, promotes protein synthesis through mRNA translation, while at the same time activating vasculogenesis.5 This increase in capillary density is a fundamental component of the cardiac response to stress since it counterbalances the augmented demand for oxygen by increasing its supply. On the other hand, in the absence of Akt, angiogenesis is impaired and the pressure-overloaded heart goes into failure more quickly.6,7 A different situation is found in exercise-induced hypertrophy, where the match between cardiomyocyte hypertrophy and angiogenesis is more balanced compared with the models of continuous pressure overload.8 A typical hallmark of cardiac hypertrophy, and in particular the maladaptive condition, is an overall increase in RNA synthesis.9 Generally, this is characterized by a reactivation of genes that are typically expressed at the foetal stage, such as NPPA and NPPB.4 The pro-angiogenic vascular endothelial growth factor-A (VEGF) is among the genes whose synthesis is increased during hypertrophy and its activation is regulated by Akt signalling10 and more directly by the hypoxia-inducible factor 1-alpha (HIF-1α).11 Interestingly, VEGF is produced by cardiomyocytes and enhances cell growth through its autocrine effect.12 In line with all this, accumulating evidence has demonstrated an important role of the molecular elements that control the general RNA processing in the progression to cardiac hypertrophy with particular emphasis on the RNA positive transcription elongation factor-b (P-TEFb) and its modulators, including Hexamethylene bis-acetamide inducible protein 1 (HEXIM1). In the paper by Montano et al.13 the authors studied the effects of HEXIM1 re-expression in the mouse adult heart. This gene (the human homologue of the mouse cardiac lineage protein CLP-1), was the first mammalian RNA kinase protein to be identified and has been shown to be involved in the regulation of many physiological and pathological processes, including cancer, inflammation, and neuronal degeneration as well as cardiac development and hypertrophy.14 At the structural level, HEXIM1 is composed of several domains of which (i) the N-terminal domain is a self-inhibitory domain, (ii) the central region acts as a nuclear localization signal as well as a binding domain for the 7SK small nuclear RNA, (iii) an adjacent region binds to P-TEFb, and (iv) the C-terminus binds to Cyclin T. At the molecular level, HEXIM1 acts as a transcriptional repressor by interfering with the effect of P-TEFb15 on mRNA transcription. In the catalytically inactive state, P-TEFb exists as a complex between HEXIM1, cyclin-dependent kinase 9 (Cdk9), 7SK small nuclear RNA, cyclin T, and other proteins.16 In response to various physiological and pathological stimuli, the silent P-TEFb complex is converted into a catalytically active form through dissociation of HEXIM1 from cyclin. This allows Bdr4 to bind to P-TEFb, activating Cdk9 and through interaction with and phosphorylation of RNA polymerase II leading to increased elongation activity and transcription of nascent mRNAs. Interestingly, the affinity of the bromodomain protein Brd4 to acetylated histones directs the active P-TEFb to specific regions of the genome that are epigenetically marked as transcriptionally active.17 Among the triggering stimuli are those associated with pathological hypertrophic signals. Indeed, in transgenic mice for calcineurin,18 the hypertrophic response observed in the heart is accompanied with reduced expression of HEXIM1 with a consequential activation of P-TEFb.19 Similar results have been obtained in cultured cardiac myocytes where stimulation with hypertrophic agonists caused the switch from the inactive to the active state of P-TEFb. Thus, HEXIM1 possibly represents a key modulator of the dynamic equilibrium of P-TEFb between the inactive and the active state and in doing so contributes to the global transcriptional regulation of a wide range of mRNAs associated with physiological and pathological cellular processes. This might represent a fine tuning modulation system for the control of cellular homoeostasis. Furthermore, several pieces of evidence have shown that the HEXIM1/P-TEFb pathway can promote the expression of specific genes recruited by specific transcription factors.20 For example, it has been shown that HEXIM1 can directly bind to and modulate transcription factors, such as the oestrogen receptor alpha, CCAAT/enhancer-binding protein alpha, and nuclear factor-kappa β.21 Taken together these data highlight a mechanism whereby the increase in P-TEFb activity is involved in increasing the global rate of RNA synthesis, thus contributing to the hypertrophic response in cardiomyocytes. In line with this, a lethal foetal phenotype together with a clear evidence of myocardial hypertrophy has been shown in null mice for HEXIM1.22 A similar phenotype has been reported for a mutant mouse expressing a truncated form of HEXIM1 in which its C-terminal domain is absent.23 More specifically, this transgenic mouse showed prenatal lethality with significant evidence of several heart defects such as abnormal coronary distribution, decreased vascularization, and thinner ventricular walls. Moreover, it is worth mentioning that overexpression of cyclin T or Cdk9 was found to provoke specific activation of P-TEFb that was associated with hypertrophic growth and acceleration of the progression to heart failure.24 Although the expression level of HEXIM1 is high during embryonic development and the early postnatal period, it is gradually reduced at the adult stage.25,26 Montano et al.13 determined the effects of acute reactivation of HEXIM1 in the adult heart. The authors generated an inducible and cardiac-specific transgenic mouse for HEXIM1 and showed that it up-regulates the protein level and thus activity of HIF-1α through direct interaction, leading to up-regulation of VEGF, suggesting that HEXIM1 is fundamental for the regulation of VEGF gene expression. Interestingly, the authors also found down-regulation of genes related to glucose metabolism and a concomitant up-regulation of genes associated with fatty acid utilization. The absence of activation of typical stress genes, such as NPPA and NPPB, led the authors to speculate that HEXIM1 overexpression induces a hypertrophy that more resembles exercise-induced rather than pressure-overload induced hypertrophy. In that respect, it is intriguing that HEXIM1 re-expression induces bradycardia without any compromise of other cardiomechanical parameters. It should be pointed out that the activation state of other major signalling pathway molecules involved in pressure-overload or exercise-induced hypertrophy (such as MAPK, mTOR, calcineurin, etc.) was not determined. Care should be taken when data are extrapolated from transgenic mouse models in which non-physiological levels of the transgene are reached during activation. The fact that the majority of the endogenous HEXIM1 is not associated with P-TEFb suggests the possibility that P-TEFb itself may play a role in hypertrophy. Moreover, the equilibrium between P-TEFb complexes is further controlled by additional regulators and several phosphatases, such as PP2B and PP1A, which have been involved in the dephosphorylation and thus deactivation of Cdk9.27 Montano et al. suggest a significant role of HEXIM1 on cardiac angiogenesis and its possible role in promoting adaptive cardiac hypertrophy (Figure 1). Schematic model of HEXIM1activity. HEXIM1 controls mRNA elongation and gene expression by modulating pTEF-b activity and through a direct effect on specific transcription factors. Conflict of interest: none declared. G.C. is supported by grants from Fundation LeDucq, Fondazione CARIPLO (grant number 12-4-5157157-3) and ERC ‘Advanced’ ‘CardioEpigen’.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
久别完成签到,获得积分10
5秒前
6秒前
seeyou14发布了新的文献求助20
13秒前
负责的初柔完成签到 ,获得积分10
17秒前
Aman完成签到,获得积分10
21秒前
心如止水完成签到 ,获得积分10
28秒前
英俊的谷蓝完成签到,获得积分10
30秒前
alei089完成签到 ,获得积分10
32秒前
田田完成签到 ,获得积分10
37秒前
包子完成签到 ,获得积分10
41秒前
Aman完成签到,获得积分10
44秒前
清脆的飞阳完成签到,获得积分10
45秒前
斯文败类的应助被躺平写文章采纳,获得10
1分钟前
herpes完成签到 ,获得积分0
1分钟前
1分钟前
1分钟前
Zhao完成签到 ,获得积分10
1分钟前
欣欣完成签到,获得积分10
1分钟前
1分钟前
忧伤的傲芙完成签到,获得积分10
1分钟前
小元元完成签到 ,获得积分10
1分钟前
微笑的巧蕊完成签到 ,获得积分10
1分钟前
躺平写文章完成签到,获得积分10
1分钟前
专注湘完成签到,获得积分10
1分钟前
Cosmosurfer完成签到,获得积分0
1分钟前
眯眯眼的安雁完成签到 ,获得积分10
1分钟前
害羞雪珊完成签到,获得积分10
2分钟前
温柔樱桃完成签到 ,获得积分10
2分钟前
满意的伊完成签到,获得积分10
2分钟前
魔幻的松思完成签到,获得积分10
2分钟前
飞哥与小佛完成签到,获得积分10
2分钟前
2分钟前
Julian完成签到,获得积分0
2分钟前
从容美女发布了新的文献求助10
2分钟前
seeyou14发布了新的文献求助20
2分钟前
健忘初露完成签到,获得积分10
2分钟前
YANGMJ完成签到,获得积分10
2分钟前
汉堡包的应助被科研通管家采纳,获得50
2分钟前
n01W97的应助被科研通管家采纳,获得20
2分钟前
Orange的应助被科研通管家采纳,获得10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185483
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783085
什么是DOI,文献DOI怎么找? 3434576
关于科研通互助平台的介绍 2558929
邀请新用户注册赠送积分活动 2481346